Talasaz AmirAli's Form 4 filing
Guardant Health, Inc. (GH) · filed Aug 24, 2026
- Accession no.
- 0001753159-26-000020
- Filed
- Aug 24, 2026, 5:21 PM ET
- Trade date
- Aug 21, 2026
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $6.34M. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Talasaz AmirAliCIK 0001753159 | Director, Officer (Co-Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 21, 2026 | Common Stock | SSaleDisposed | −9,023 | $168.20 | −$1,517,630.7 | 65,977 | Indirect | |
| Aug 21, 2026 | Common Stock | SSaleDisposed | −20,888 | $169.16 | −$3,533,451.68 | 45,089 | Indirect | |
| Aug 21, 2026 | Common Stock | SSaleDisposed | −7,589 | $170.29 | −$1,292,301.97 | 37,500 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.